Redox Biology (Nov 2023)

Mesenchymal stem cell attenuates spinal cord injury by inhibiting mitochondrial quality control-associated neuronal ferroptosis

  • Senyu Yao,
  • Mao Pang,
  • Yanheng Wang,
  • Xiaokang Wang,
  • Yaobang Lin,
  • Yanyan Lv,
  • Ziqi Xie,
  • Jianfeng Hou,
  • Cong Du,
  • Yuan Qiu,
  • Yuanjun Guan,
  • Bin Liu,
  • Jiancheng Wang,
  • Andy Peng Xiang,
  • Limin Rong

Journal volume & issue
Vol. 67
p. 102871

Abstract

Read online

Ferroptosis is a newly discovered form of iron-dependent oxidative cell death and drives the loss of neurons in spinal cord injury (SCI). Mitochondrial damage is a critical contributor to neuronal death, while mitochondrial quality control (MQC) is an essential process for maintaining mitochondrial homeostasis to promote neuronal survival. However, the role of MQC in neuronal ferroptosis has not been clearly elucidated. Here, we further demonstrate that neurons primarily suffer from ferroptosis in SCI at the single-cell RNA sequencing level. Mechanistically, disordered MQC aggravates ferroptosis through excessive mitochondrial fission and mitophagy. Furthermore, mesenchymal stem cells (MSCs)-mediated mitochondrial transfer restores neuronal mitochondria pool and inhibits ferroptosis through mitochondrial fusion by intercellular tunneling nanotubes. Collectively, these results not only suggest that neuronal ferroptosis is regulated in an MQC-dependent manner, but also fulfill the molecular mechanism by which MSCs attenuate neuronal ferroptosis at the subcellular organelle level. More importantly, it provides a promising clinical translation strategy based on stem cell-mediated mitochondrial therapy for mitochondria-related central nervous system disorders.

Keywords